Parathormone - 25(OH)-vitamin D axis and bone status in children and adolescents with type 1 diabetes mellitus

Pediatric Diabetes

Volumn 12, Issue 6, 2011, Pages 536-546

  Hamed, Enas A ^a   Abu Faddan, Nagla H ^b   Adb Elhafeez, Hebh A ^a   Sayed, Douaa ^a  

^a Assiut University Faculty of Medicine   (Egypt)

^b ASSIUT UNIVERSITY   (Egypt)

Author keywords

25(OH)D; Bone status; IGF 1; PTH; TIDM

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; HEMOGLOBIN A1C; PARATHYROID HORMONE; PHOSPHATE; SOMATOMEDIN C;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; AUTOANALYZER; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIABETIC PATIENT; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LUMBAR SPINE; MALE; METABOLIC REGULATION; OSTEOPENIA; OSTEOPOROSIS; PELVIS; PRIORITY JOURNAL; PUBERTY; RIB; THORACIC SPINE;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; BODY MASS INDEX; BONE AND BONES; CALCIUM; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; PARATHYROID HORMONE; PHOSPHATES; VITAMIN D;

EID: 80051947921     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00739.x     Document Type: Article

References (66)

1. Ambler G, Fairchild J, Craig M, Cameron F. Contemporary Australian outcomes in childhood and adolescent type 1 diabetes: 10 years post the Diabetes Control and Complications Trial. J Paediatr Child Health 2006: 42: 403-410.
2. Holmberg A, Johnell O, Nilsson P, Nilsson J, Berglund G, Akesson K. Risk factors for fragility fracture in middle age. A prospective population-based study of 33, 000 men and women. Osteoporos Int 2006: 17: 1065-1077.
3. De Schepper J, Smitz J, Rosseneu S, Bollen P, Louis O. Lumbar spine bone mineral density in diabetic children with recent onset. Horm Res 1998: 50: 193-196.
4. Brandao F, Vicente E, Daltro C, Sacramento M, Moreira A, Adan L. Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus. Diabetes Res Clin Pract 2007: 78: 334-339.
5. Leger J, Marinovic D, Alberti C et al. Lower bone mineral content in children with type 1diabetes mellitus is linked to female sex, low insulin- like growth factor type 1 levels, and high insulin requirement. J Clin Endocrinol 2006: 91: 3947-3953.
6. Saggese G, Baroncelli GI, Bertelloni S. Puberty and bone development. Best Pract Res Clin Endocrinol Metab 2002: 16: 53-64.
7. Bloch CA, Clemons P, Sperling MA. Puberty decreases insulin sensitivity. J Pediatr 1987: 110: 481-487.
8. Yakar S, Rosen C, Beamer W et al. Circulating levels of IGF-1 directly regulates bone growth and density. J Clin Invest 2002: 110: 771-781.
9. Holick M. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers and cardiovascular disease. Am J Clin Nutr 2004: 80: 1678S-1688S.
10. Cashman K. Calcium and vitamin D. Novartis Found Symp 2007: 282: 123-138.
11. Zold E, Szodoray P, Gaal J et al. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther 2008: 10: R123 (DOI: 10.1186/ar2533).
12. Maalouf G, Gannagé-Yared MH, Ezzedine J et al. Middle East and North Africa consensus on osteoporosis. J Musculoskelet Neuronal Interact 2007: 7: 131-143.
13. Pettifor JM. Nutritional rickets: deficiency of vitamin D, calcium, or both? Am J Clin Nutr 2004: 80: 1725S-1729S.
14. Thacher TD, Fischer PR, Strand MA, Pettifor JM. Nutritional rickets around the world: causes and future directions. Ann Trop Paediatr 2006: 26: 1-16.
15. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001: 22: 477-501.
16. Rewers M, Norris J, Dabelea D. Epidemiology of type 1 diabetes mellitus. Adv Exp Med Biol 2004: 552: 219-246.
17. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005: 48: 1247-1257.
18. Zeitz U, Weber K, Soegiarto D, Wolf E, Balling R, Erben R. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 2003: 17: 509-511.
19. Gysemans C, Cardozo A, Callewaert H et al. 1, 25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in non-obese diabetic mice. Endocrinology 2005: 146: 1956-1964.
20. Adams J, Liu P, Chun R, Modlin R, Hewison M. Vitamin D in defense of the human immune response. Ann N Y Acad Sci 2007: 1117: 94-105.
21. Poole K, Reeve J. Parathyroid hormone - a bone anabolic and catabolic agent. Curr Opin Pharmacol 2005: 5: 612-617.
22. Whitfield J, Morley P, Willick G. Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis. Treat Endocrinol 2002: 1: 175-190.
23. Garay-Sevilla M, Nava L, Malacara J, Wróbel K, Perez U. Advanced glycosylation end products, insulin-like growth factor-1 and IGF-binding protein-3 in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 2000: 16: 106-113.
24. Pereira R, Canalis E. Parathyroid hormone increases mac25/insulin-like growth factor-binding protein-related protein-1 expression in cultured osteoblasts. Endocrinology 1999: 140: 1998-2003.
25. Farley J, Dimai H, Stilt-Coffing B, Farley P, Pham T, Mohan S. Calcitonin increases the concentration of insulin-like growth factors in serum-free cultures of human osteoblast-line cells. Calcif Tissue Int 2000: 67: 247-254.
26. Pastor MMC, Lopez-Ibarra PJ, Escobar-Jimenez F, Pardo SMD, Garcia-Cervigon A. Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporos Int 2000: 11: 455-459.
27. Taylor S, Whincup P, Hindmarsh P, Lampe F, Odoki K, Cook D. Performance of a new pubertal self-assessment questionnaire: a preliminary study. Paediatr Perinat Epidemiol 2001: 15: 88-94.
28. Heap J, Murray M, Miller S, Jalili T, Moyer-Mileur L. Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus. J Pediatr 2004: 144: 56-62.
29. Iwanicka Z, Lewandowicz-Uszyńska A, Glab E, Kotschy B. Relationship between nitrogen oxide and the degree of metabolic control of diabetes mellitus type 1 in children and adolescents. Wiad Lek 2006: 59: 27-31.
30. Schlosser K, Schmitt CP, Bartholomaeus JE et al. Parathyroidectomy for renal hyperparathyroidism in children and adolescents. World J Surg 2008: 32: 801-806.
31. Eren E, Yilmaz N. Biochemical markers of bone turnover and bone mineral density in patients with b-thalassemia major. Int J Clin Pract 2005: 59: 46-51.
32. Carnevale V, Romagnoli E, D'Erasmo E. Skeletal involvement in patients with diabetes mellitus. Diabetes Metab Res Rev 2004: 20: 196-204.
33. Littorin B, Blom P, Scholin A et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006: 49: 2847-2852.
34. Zemunik T, Skrabic V, Boraska V et al. FokI polymorphism, vitamin D receptor, and interleukin-1 receptor haplotypes are associated with type 1 diabetes in the Dalmatian population. J Mol Diagn 2005: 7: 600-604.
35. Huynh T, Greer R, Nyunt O et al. The association between ketoacidosis and 25(OH)-vitamin D3 levels at presentation in children with type 1 diabetes mellitus. Pediatr Diabetes 2009: 10: 38-43.
36. Kawashima H, Kraut JA, Kurokawa K. Metabolic acidosis suppresses 25-hydroxyvitamin in D3-1alphahydroxylase in the rat kidney. Distinct site and mechanism of action. J Clin Invest 1982: 70: 135-140.
37. Svoren BM, Volkening LK, Wood JR, Laffel LMB. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatr 2009: 154: 132-134.
38. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005: 16: 713-716.
39. Nejentsev S, Cooper J, Godfrey L et al. Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. Diabetes 2004: 53: 2709-2712.
40. Pozzilli P, Manfrini S, Crinò A et al. Low levels of 25- hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res 2005: 37: 680-683.
41. Malabanan A, Veronikis I, Holick M. Redefining vitamin D insufficiency. Lancet 1998: 351: 805-806.
42. Kemink S, Hermus A, Swinkels L, Lutterman J, Smals A. Osteopenia in insulin-dependent diabetes mellitus: prevalence and aspects of pathophysiology. J Endocrinol Invest 2000: 23: 295-303.
43. Sugimoto T, Ritter C, Morrissey J, Hayes C, Slatopolsky E. Effects of high concentrations of glucose on PTH secretion in parathyroid cells. Kidney Int 1990: 37: 1522-1527.
44. Zitterman A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003: 89: 552-572.
45. Taylor WH, Khaleeli AA. Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev 2001: 17: 175-180.
46. Kleerekoper M, Nelson DA, Peterson EL et al. Reference data for bone mass, calciotropic hormone, and biochemical markers of bone remodelling in older (55-75) postmenopausal white and black women. J Bone Miner Res 1994: 9: 1267-1276.
47. Miyakoshi N, Kasukawa Y, Linkhart T, Baylink D, Mohan S. Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology 2001: 142: 4349-4356.
48. Suzuki A, Kotake M, Ono Y et al. Hypovitaminosis D in type 2 diabetes mellitus: association with microvascular complications and type of treatment. Endocr J 2006: 53: 503-510.
49. Emily Y, Wactwski-Wende J, Richard P, Dmochowski J, Hovey K, Quattrin T. Dose low bone mineral density start in post-teenage years in women with type 1 diabetes? Diabetes Care 2003: 26: 2365-2369.
50. Tamborlane W, Hintz R, Bergman M, Genel M, Felig P, Sherwin R. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. N Engl J Med 1981: 305: 303-307.
51. Cohen M, Jastik A, Rye D. Somatomedin in insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1977: 45: 236-239.
52. Frost R, Lang C, Gelato M. Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology 1997: 138: 4153-4159.
53. Kanda F, Okuda S, Matsushita T, Takatani K, Kimura K, Chihara K. Steroid myopathy: pathogenesis and effects of growth hormone and insulin-like growth factor-I administration. Horm Res 2001: 56: 24-28.
54. Reed B, Zerwekh H, Sakhaee K, Breslau N, Gottschalk F, Pak C. Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 1995: 10: 1218-1224.
55. Frystyk J, Ritzel R, Maubach J et al. Comparison of pancreas-transplanted type 1 diabetic patients with portal venous versus systemic-venous graft drainage: impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-I axis. J Clin Endocrinol Metab 2008: 93: 1758-1766.
56. Rix M, Andreassen H, Eskildsen P. Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care 1999: 22: 827-831.
57. Campos-Pastor M, Lopez-Ibarra P, Escobar-Jimenez F, Serrano-Pardo M, Garcia-Cervigon G. Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: A prospective study. Osteoporos Int 2000: 11: 455-459.
58. Gunczler P, Lanes R, Paz-Martinez V et al. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol Metab 1998: 11: 413-419.
59. Pascual J, Argente J, Lopez M et al. Bone mineral density in children and adolescents with diabetes mellitus type 1 of recent onset. Calcif Tissue Int 1998: 62: 31-35.
60. Bass S, Delmas P, Pearce G, Hendrich E, Tabensky A, Seeman E. The differing tempo of growth in bone size, mass, and density in girls is region-specific. J Clin Invest 1999: 104: 795-804.
61. Botolin S, McCabe L. Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 2006: 99: 411-424.
62. Alexopoulou O, Jamart J, Devogelaer J, Brichard S, de Nayer P, Buysschaert M. Bone density and markers of bone remodeling in type 1 male diabetic patients. Diabetes Metab 2006: 32: 453-458.
63. Lopez-Ibarra P, Pastor M, Escobar-Jimenez F et al. Bone mineral density at time of clinical diagnosis in adult-onset type 1 diabetes mellitus. Endocr Prac 2001: 7: 346-351.
64. Bonfanti R, Mora S, Prinster C et al. Bone modeling indexes at onset and during the first year of follow-up in insulin dependent diabetic children. Calcif Tissue Int 1997: 60: 397-400.
65. Gunczler P, Lanes P, Paoli M, Martins R, Villaroel O, Weisinger J. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2001: 14: 525-528.
66. Saggese G, Bertelloni S, Baroncelli G, Federico G, Calisti L, Fusaro C. Bone demineralization and impaired mineral metabolism in insulin-dependent diabetes mellitus: a possible role of magnesium deficiency. Helv Paediatr Acta 1989: 43: 405-414.